Paul T. Quinlan
CIK: 0001333277
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Oruka Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (24 total)
- Oct 20, 2026ORKA
Oruka Therapeutics, Inc.
Sale(S)Direct1K shares at avg. $77.20$77K - Oct 20, 2026ORKA
Oruka Therapeutics, Inc.
Sale(S)Direct3K shares at avg. $79.49$238K - Oct 20, 2026ORKA
Oruka Therapeutics, Inc.
Exercise(M)Direct9K shares at avg. $7.80$70K - Oct 20, 2026ORKA
Oruka Therapeutics, Inc.
Sale(S)Direct400 shares at avg. $74.90$30K - Oct 20, 2026ORKA
Oruka Therapeutics, Inc.
Sale(S)Direct500 shares at avg. $76.12$38K - Oct 20, 2026ORKA
Oruka Therapeutics, Inc.
Sale(S)Direct4.1K shares at avg. $78.79$323K - Sep 21, 2026ORKA
Oruka Therapeutics, Inc.
Exercise(M)Direct10K shares at avg. $7.80$78K - Sep 21, 2026ORKA
Oruka Therapeutics, Inc.
Sale(S)Direct2.9K shares at avg. $92.37$268K - Sep 21, 2026ORKA
Oruka Therapeutics, Inc.
Sale(S)Direct3.8K shares at avg. $93.32$358K - Sep 21, 2026ORKA
Oruka Therapeutics, Inc.
Sale(S)Direct601 shares at avg. $94.44$57K - Sep 21, 2026ORKA
Oruka Therapeutics, Inc.
Sale(S)Direct2.7K shares at avg. $95.31$254K - Sep 15, 2026ORKA
Oruka Therapeutics, Inc.
Sale(S)Direct1K shares at avg. $95.71$99K - Aug 14, 2026ORKA
Oruka Therapeutics, Inc.
Sale(S)Direct10.4K shares at avg. $107.14$1.1M - Aug 14, 2026ORKA
Oruka Therapeutics, Inc.
Sale(S)Direct10.2K shares at avg. $109.11$1.1M - Aug 14, 2026ORKA
Oruka Therapeutics, Inc.
Sale(S)Direct9.2K shares at avg. $110.00$1.0M - Aug 14, 2026ORKA
Oruka Therapeutics, Inc.
Sale(S)Direct3.8K shares at avg. $111.14$428K - Aug 14, 2026ORKA
Oruka Therapeutics, Inc.
Sale(S)Direct14.7K shares at avg. $107.97$1.6M - Aug 14, 2026ORKA
Oruka Therapeutics, Inc.
Exercise(M)Direct10K shares at avg. $7.80$78K - Aug 14, 2026ORKA
Oruka Therapeutics, Inc.
Exercise(M)Direct42K shares at avg. $12.50$525K - Aug 14, 2026ORKA
Oruka Therapeutics, Inc.
Sale(S)Direct3.6K shares at avg. $106.05$385K - Jun 15, 2026ORKA
Oruka Therapeutics, Inc.
Sale(S)Direct733 shares at avg. $69.69$51K - Mar 16, 2026ORKA
Oruka Therapeutics, Inc.
Sale(S)Direct733 shares at avg. $41.30$30K - Jan 23, 2026ORKA
Oruka Therapeutics, Inc.
Award(A)Direct32.5K shares- - Jan 22, 2025ORKA
Oruka Therapeutics, Inc.
Award(A)DirectEmployee Stock Option (right to buy)
162.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 20, 2026 | ORKA Oruka Therapeutics, Inc. | Sale(S) | 1,000 | $77.20 | $77,205 | Direct |
| Oct 20, 2026 | ORKA Oruka Therapeutics, Inc. | Sale(S) | 3,000 | $79.49 | $238,474 | Direct |
| Oct 20, 2026 | ORKA Oruka Therapeutics, Inc. | Exercise(M) | 9,000 | $7.80 | $70,200 | Direct |
| Oct 20, 2026 | ORKA Oruka Therapeutics, Inc. | Sale(S) | 400 | $74.90 | $29,960 | Direct |
| Oct 20, 2026 | ORKA Oruka Therapeutics, Inc. | Sale(S) | 500 | $76.12 | $38,059 | Direct |
| Oct 20, 2026 | ORKA Oruka Therapeutics, Inc. | Sale(S) | 4,100 | $78.79 | $323,037 | Direct |
| Sep 21, 2026 | ORKA Oruka Therapeutics, Inc. | Exercise(M) | 10,000 | $7.80 | $78,000 | Direct |
| Sep 21, 2026 | ORKA Oruka Therapeutics, Inc. | Sale(S) | 2,900 | $92.37 | $267,870 | Direct |
| Sep 21, 2026 | ORKA Oruka Therapeutics, Inc. | Sale(S) | 3,832 | $93.32 | $357,592 | Direct |
| Sep 21, 2026 | ORKA Oruka Therapeutics, Inc. | Sale(S) | 601 | $94.44 | $56,760 | Direct |
| Sep 21, 2026 | ORKA Oruka Therapeutics, Inc. | Sale(S) | 2,667 | $95.31 | $254,196 | Direct |
| Sep 15, 2026 | ORKA Oruka Therapeutics, Inc. | Sale(S) | 1,039 | $95.71 | $99,443 | Direct |
| Aug 14, 2026 | ORKA Oruka Therapeutics, Inc. | Sale(S) | 10,434 | $107.14 | $1,117,901 | Direct |
| Aug 14, 2026 | ORKA Oruka Therapeutics, Inc. | Sale(S) | 10,200 | $109.11 | $1,112,954 | Direct |
| Aug 14, 2026 | ORKA Oruka Therapeutics, Inc. | Sale(S) | 9,193 | $110.00 | $1,011,266 | Direct |
| Aug 14, 2026 | ORKA Oruka Therapeutics, Inc. | Sale(S) | 3,847 | $111.14 | $427,547 | Direct |
| Aug 14, 2026 | ORKA Oruka Therapeutics, Inc. | Sale(S) | 14,696 | $107.97 | $1,586,779 | Direct |
| Aug 14, 2026 | ORKA Oruka Therapeutics, Inc. | Exercise(M) | 10,000 | $7.80 | $78,000 | Direct |
| Aug 14, 2026 | ORKA Oruka Therapeutics, Inc. | Exercise(M) | 42,000 | $12.50 | $525,000 | Direct |
| Aug 14, 2026 | ORKA Oruka Therapeutics, Inc. | Sale(S) | 3,630 | $106.05 | $384,963 | Direct |
| Jun 15, 2026 | ORKA Oruka Therapeutics, Inc. | Sale(S) | 733 | $69.69 | $51,083 | Direct |
| Mar 16, 2026 | ORKA Oruka Therapeutics, Inc. | Sale(S) | 733 | $41.30 | $30,273 | Direct |
| Jan 23, 2026 | ORKA Oruka Therapeutics, Inc. | Award(A) | 32,500 | - | $0 | Direct |
| Jan 22, 2025 | ORKA Oruka Therapeutics, Inc. | Award(A) Employee Stock Option (right to buy) | 162,500 | - | - | Direct |
1-24 of 24 transactions
About Quinlan Paul T
Quinlan Paul T (SEC CIK 0001333277) files insider reports with the SEC as General Counsel of Oruka Therapeutics, Inc. (ORKA).
Signal8 holds 9 ownership filings by Quinlan Paul T (1 Form 3, 8 Form 4), filed between Sep 6, 2024 and Oct 20, 2026. Those filings report 24 transactions, from Jan 22, 2025 to Oct 20, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Quinlan Paul T's filings is in MENLO PARK, CA.
Recent filings by Quinlan Paul T
- Oct 20, 2026: Open-market sales of ORKA shares (2 lines, Form 4, code S).
- Oct 20, 2026: Option exercise of ORKA shares (Form 4, code M).
- Oct 20, 2026: Open-market sales of ORKA shares (3 lines, Form 4, code S).
- Sep 21, 2026: Option exercise of ORKA shares (Form 4, code M).
- Sep 21, 2026: Open-market sales of ORKA shares (4 lines, Form 4, code S).
Other insiders filing for Oruka Therapeutics, Inc. (ORKA)
- Klein Lawrence Otto, Chief Executive Officer
- Goncalves Joana, Chief Medical Officer
- Agarwal Arjun, Senior Vice President, Finance
- Sandler Laura Lee, Chief Operating Officer
- Edwards Larry Todd, Chief Commercial Officer
- Fairmount Funds Management LLC, Director